← Back to Search

Biologic Care Pathway for Inflammatory Bowel Disease

N/A
Recruiting
Research Sponsored by Jennifer Jones
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the use of standardized care pathways for patients with Inflammatory Bowel Disease (IBD) to improve treatment outcomes. The researchers will investigate how implementing a Biologic Care Pathway

Who is the study for?
This trial is for adults over 18 with Crohn's Disease, Ulcerative Colitis, or other IBDs who are starting anti-TNF biologic therapy. It excludes those with severe intestinal complications, active infections, cancer, or any reason they can't have biologic treatments.
What is being tested?
The study tests a Biologic Care Pathway (BCP) to see if it improves patient outcomes in IBD treatment compared to usual care without BCP. The focus is on the integration of BCP into clinical practice and its effects on health outcomes and healthcare efficiency.
What are the potential side effects?
While specific side effects aren't listed for the pathway itself, typical risks associated with anti-TNF biologics include infection risk increase, potential allergic reactions, and possible worsening of heart failure among others.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
EQ5D Score
Secondary study objectives
Emergency room visits
ambulatory care visits
disease-related surgery
+2 more
Other study objectives
CRP concentration
Fecal calprotectin
HBI Index Score
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Biologic Care PathwayExperimental Treatment1 Intervention
Care through a biologic care pathway
Group II: ControlActive Control1 Intervention
Care as usual

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityOTHER
288 Previous Clinical Trials
94,380 Total Patients Enrolled
Jennifer JonesLead Sponsor
2 Previous Clinical Trials
120 Total Patients Enrolled
~50 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top